The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer.
Radosa JC, Kasoha M, Doerk M, Cullmann A, Kaya AC, Linxweiler M, Radosa MP, Takacs Z, Tirincsi A, Lang S, Jung M, Puppe J, Linxweiler B, Wagner M, Bohle RM, Solomayer EF, Zimmermann JSM.
Radosa JC, et al. Among authors: kasoha m.
Int J Mol Sci. 2023 May 31;24(11):9576. doi: 10.3390/ijms24119576.
Int J Mol Sci. 2023.
PMID: 37298528
Free PMC article.